All BRC facilities are now approved to resume services. We will share detailed changes to procedures, and timelines for the availability of services as soon as possible through mailings and on this website. We look forward to serving our research community as we move to a new (and evolving) normal during this phased process. The safety of our staff and the researchers who depend on our services is paramount. Throughout it all, we kindly ask for your continued patience and understanding.

Welcome you on our new website! If you encounter any issue, let us know by emailing us at: biotech-comm@cornell.edu

Congratulations to Sheng Zhang and Robert Sherwood from our Proteomics and Metabolomics Facility for their contribution to this breakthrough on #COVID19 research.

A new Epigenomics Facility, part of the Integrated Genome Biology Core (IGBC), will be administered by the BRC.